Holterhus P M, Werner R, Hoppe U, Bassler J, Korsch E, Ranke M B, Dörr H G, Hiort O
Department of Paediatrics, University Hospital Schleswig-Holstein, UKSH, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.
J Mol Med (Berl). 2005 Dec;83(12):1005-13. doi: 10.1007/s00109-005-0704-y. Epub 2005 Nov 11.
Androgen insensitivity syndrome (AIS) is characterized by deficient or absent virilization in 46,XY individuals despite normal or even elevated androgen levels. AIS is usually caused by mutations in the androgen receptor (AR) gene. We aimed at contrasting clinical, biochemical, and molecular genetic characteristics of three patients (P1-P3) with clinically evident partial (P1) and complete (P2, P3) AIS with and without AR gene mutations. AR expression was studied in cultured genital skin fibroblasts (GSF) by Western immunoblotting, ligand binding analyses, Northern blotting, semiquantitative reverse transcription-polymerase chain reaction (RT-PCR), and RT-PCR spanning exons 1-8. AR gene DNA sequence was analyzed by single-strand conformation analysis (SSCA), and DNA sequencing. GSF revealed reduced (P1) or absent (P2, P3) ligand binding. Northern blots showed either slightly reduced hybridization of the 10.5-kb AR transcript (P3) or no hybridization (P1, P2), as confirmed by semiquantitative RT-PCR. RT-PCR spanning exons 1-8 detected single AR mRNA bands in P1-P3 excluding splicing errors. Western analyses showed either low (P1) or no (P2, P3) AR protein. While SSCA initially did not reveal any molecular abnormality, sequencing showed a novel CAG (Gln) to TAG (stop) mutation at codon 59 (P3) and a previously described 2-bp deletion at codon 472, leading to a frameshift and premature stop in codon 499 (P2). Intriguingly, P1 showed an unaltered DNA sequence of the coding region of the AR gene including all intron-exon boundaries. In conclusion, patients with clinically evident complete AIS are likely to harbor an AR gene mutation, demanding that the two polymorphic regions must always be included in molecular analyses of the AR gene. Moreover, our data support the concept that in a subset of AIS patients, particularly those with partial AIS, molecular alterations outside the coding region of the AR gene must be presumed.
雄激素不敏感综合征(AIS)的特征是,46,XY个体尽管雄激素水平正常甚至升高,但男性化不足或缺乏。AIS通常由雄激素受体(AR)基因突变引起。我们旨在对比三名临床症状明显的部分性(P1)和完全性(P2、P3)AIS患者的临床、生化和分子遗传学特征,其中两名患者(P2、P3)存在AR基因突变,一名患者(P1)不存在该突变。通过蛋白质免疫印迹法、配体结合分析、Northern印迹法、半定量逆转录聚合酶链反应(RT-PCR)以及跨越外显子1-8的RT-PCR,对培养的生殖器皮肤成纤维细胞(GSF)中的AR表达进行了研究。通过单链构象分析(SSCA)和DNA测序对AR基因的DNA序列进行了分析。GSF显示配体结合减少(P1)或缺失(P2、P3)。Northern印迹显示,10.5 kb的AR转录本杂交略有减少(P3)或无杂交信号(P1、P2),半定量RT-PCR证实了这一结果。跨越外显子1-8的RT-PCR在P1-P3中检测到单一的AR mRNA条带,排除了剪接错误。蛋白质印迹分析显示AR蛋白水平低(P1)或无(P2、P3)。虽然SSCA最初未发现任何分子异常,但测序显示在第59密码子处有一个新的CAG(谷氨酰胺)到TAG(终止密码子)的突变(P3),以及先前描述的第472密码子处2个碱基的缺失,导致第499密码子处移码和提前终止(P2)。有趣的是,P1的AR基因编码区DNA序列未改变,包括所有内含子-外显子边界。总之,临床症状明显的完全性AIS患者可能存在AR基因突变,这就要求在AR基因的分子分析中必须始终包括两个多态性区域。此外,我们的数据支持这样一种观点,即在一部分AIS患者中,尤其是部分性AIS患者,必须推测AR基因编码区以外存在分子改变。